Clinical Cardiology Alert – November 1, 2008
November 1, 2008
View Issues
-
Should We RELOAD Patients on Long-term Clopidogrel?
Platelet inhibition with clopidogrel has become an important weapon against recurrent coronary events in patients with coronary artery disease. However, recent evidence shows that patient response to clopidogrel is variable, with some patients having suboptimal inhibition of platelet aggregation. -
Management of Type B Aortic Dissection
Uncomplicated type B aortic dissection (origin distal to left subclavian artery) is usually treated medically. However, early mortality is 10%-12%, and is due to complications. -
Appropriate Utilization of EMS Services
The cardiac arrest registry to enhance survival (CARES) is a registry designed to help local emergency medical system officials monitor outcomes of out-of-hospital resuscitation. -
Discordant Results of Exercise Echo and ECG
Since both treadmill exercise ECG and echo have independent prognostic value when studied alone, what does the ECG response add to a negative exercise echo? -
Esophageal Injury during RF Ablation Procedures
In this report, Singh et al report a two hospital study on the use of esophageal temperature monitoring during atrial fibrillation ablation procedures. -
Best Medical Therapy vs Revascularization for Stable Angina: The Beat Goes on!
A long-standing controversy exists regarding use of angioplasty (PCI) vs best or optimal medical therapy in subjects with stable coronary disease (CAD). -
Pharmacology Watch
Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions. -
Clinical Briefs in Primary Care supplement